← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 4, 2021Last known activity
Apr 14, 2023
Timeline
2010s
- Jun 1, 2011
Elicio Therapeutics— Founded
2020s
- Jan 17, 2023
Angion Biomedica Corp— Acquired
Drugs by trial phase (5 distinct, 15 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (1 own, 2 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (3)
- NCT07083479Lead sponsorN/A—
- NCT05726864Lead sponsorPhase 1/Phase 2Apr 14, 2023
- NCT04853017Lead sponsorPhase 1Oct 4, 2021
Details
- Founded
- Cambridge, MA, US Jun 1, 2011
- Last known activity
- Apr 14, 2023